Drug
Lidocaine Patch
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Product Adhesion Issue | 2,863 | 385.8 | 960.8 | signal |
| 2 | Drug Ineffective For Unapproved Indication | 1,263 | 101.7 | 137.9 | signal |
| 3 | Product Quality Issue | 2,679 | 89.0 | 201.2 | signal |
| 4 | Application Site Irritation | 75 | 26.6 | 27.0 | signal |
| 5 | Application Site Rash | 74 | 23.7 | 24.0 | signal |
| 6 | Product Availability Issue | 85 | 16.7 | 17.0 | signal |
| 7 | Expired Product Administered | 114 | 15.1 | 15.5 | signal |
| 8 | Application Site Pain | 68 | 13.6 | 13.8 | signal |
| 9 | Inability To Afford Medication | 27 | 12.1 | 12.1 | signal |
| 10 | Application Site Pruritus | 60 | 11.6 | 11.8 | signal |
| 11 | Application Site Erythema | 61 | 10.2 | 10.3 | signal |
| 12 | Body Height Decreased | 24 | 9.8 | 9.8 | signal |
| 13 | Incorrect Product Administration Duration | 39 | 8.4 | 8.5 | signal |
| 14 | Insurance Issue | 27 | 8.0 | 8.0 | signal |
| 15 | Spinal Operation | 22 | 8.0 | 8.0 | signal |
| 16 | No Adverse Event | 302 | 7.5 | 7.9 | signal |
| 17 | Wrong Technique In Product Usage Process | 333 | 7.2 | 7.7 | signal |
| 18 | Off Label Use | 1,412 | 7.1 | 9.7 | signal |
| 19 | Incorrect Drug Administration Duration | 33 | 5.1 | 5.1 | signal |
| 20 | Dermatitis Contact | 9 | 3.5 | 3.5 | signal |
| 21 | Product Packaging Issue | 7 | 3.3 | 3.3 | signal |
| 22 | Hip Arthroplasty | 10 | 2.9 | 2.9 | signal |
| 23 | Product Packaging Quantity Issue | 7 | 2.8 | 2.8 | signal |
| 24 | Drug Effect Decreased | 34 | 2.7 | 2.7 | signal |
| 25 | Knee Operation | 5 | 2.3 | 2.3 | no signal |
| 26 | Product Substitution Issue | 29 | 2.2 | 2.2 | signal |
| 27 | Product Physical Issue | 10 | 2.2 | 2.2 | signal |
| 28 | Product Use In Unapproved Indication | 113 | 2.0 | 2.1 | signal |
| 29 | Therapy Change | 4 | 1.8 | 1.8 | no signal |
| 30 | Inappropriate Schedule Of Drug Administration | 29 | 1.8 | 1.8 | no signal |
| 31 | Product Use Complaint | 6 | 1.7 | 1.7 | no signal |
| 32 | Scratch | 4 | 1.7 | 1.7 | no signal |
| 33 | Knee Arthroplasty | 8 | 1.7 | 1.7 | no signal |
| 34 | Middle Insomnia | 7 | 1.7 | 1.7 | no signal |
| 35 | Hypoacusis | 16 | 1.6 | 1.6 | no signal |
| 36 | Intentional Product Misuse | 27 | 1.4 | 1.4 | no signal |
| 37 | Product Administered At Inappropriate Site | 5 | 1.2 | 1.2 | no signal |
| 38 | Device Adhesion Issue | 4 | 1.2 | 1.2 | no signal |
| 39 | Skin Irritation | 12 | 1.1 | 1.1 | no signal |
| 40 | Drug Effect Incomplete | 9 | 1.1 | 1.1 | no signal |
| 41 | Product Storage Error | 17 | 0.9 | 0.9 | no signal |
| 42 | Drug Effective For Unapproved Indication | 4 | 0.6 | 0.6 | no signal |
| 43 | Skin Burning Sensation | 9 | 0.6 | 0.6 | no signal |
| 44 | Device Leakage | 5 | 0.5 | 0.5 | no signal |
| 45 | Device Difficult To Use | 5 | 0.3 | 0.3 | no signal |